STATE-OF-THE-ART PAPERAnemia as a risk factor and therapeutic target in heart failure
Under an Elsevier user license
open archive
Abbreviations and acronyms
ACE
angiotensin-converting enzyme
ESRD
end-stage renal disease
Hb
hemoglobin
HF
heart failure
NYHA
New York Heart Association
rHuEPO
recombinant human erythropoietin
TNF
tumor necrosis factor
Cited by (0)
Dr. Felker is the site principal investigator for the Study of Anemia in a Heart Failure Population (STAMINA-HFP) registry, a heart failure registry sponsored by Amgen. Dr. Adams has acted as principal investigator for the STAMINA-HFP registry and other clinical studies sponsored by Amgen. Additionally, Dr. Adams has performed consulting/advisory board activities and been on a speaker's bureau for Amgen. Dr. O'Connor has performed consulting/advisory board activities for Amgen.
Copyright © 2004 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.